{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:38:16Z","timestamp":1794947896119,"version":"4.9.1"},"reference-count":22,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,12,23]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The purpose of this study was to describe reports of congenital eye anomalies entered in the international pharmacovigilance database, with a particular focus on medications associated with this type of anomaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This descriptive, retrospective study selected reports using the adverse reaction term \u2018congenital eye disorders\u2019 and included only those instances where at least one medication was documented as being administered via the transplacental route. Statistical analyses were performed using R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We extracted 2923 reports of eye anomalies in children exposed to medications in utero and ultimately selected 676 of these. Congenital anomalies of the eyelids (17.3%), lacrimal apparatus (9.4%) and orbit (1.1%) were the most common. The suspect medications highlighted in this study include teratogenic agents known to pose a risk of triggering eye anomalies such as valproic acid and mycophenolic acid. The list also includes medications with little or no reference in the literature to potential eye anomalies following in utero exposure, such as hydroxychloroquine and ondansetron.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides new data on in utero exposure to medications and congenital eye anomalies that can be severely debilitating. This is a descriptive study, with all the inherent limitations of the pharmacovigilance databases which are used for signal detection. This descriptive study does not allow us to conclude that there is a causal link between exposure to a given medication during pregnancy and congenital eye anomalies and is a basis for future studies using different data sources and\/or other methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-002049","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:25:18Z","timestamp":1767687918000},"page":"e002049","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["In utero exposure to medications and congenital eye anomalies"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7509-1823","authenticated-orcid":false,"given":"R\u00e9jane","family":"Mairesse","sequence":"first","affiliation":[{"name":"Medical and Clinical Pharmacology Department, CHU Toulouse, Toulouse University, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0265-3182","authenticated-orcid":false,"given":"Marianne","family":"Lepetit","sequence":"additional","affiliation":[{"name":"Medical and Clinical Pharmacology Department, CHU Toulouse, Toulouse University, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-4113","authenticated-orcid":false,"given":"Charlotte","family":"Dubucs","sequence":"additional","affiliation":[{"name":"Service de G\u00e9n\u00e9tique m\u00e9dicale, CHU Toulouse, Toulouse, France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9978-3150","authenticated-orcid":false,"given":"Erika-Alejandra","family":"Cifuentes","sequence":"additional","affiliation":[{"name":"Medical and Clinical Pharmacology Department, CHU Toulouse, Toulouse University, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-0108","authenticated-orcid":false,"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[{"name":"Medical and Clinical Pharmacology Department, CHU Toulouse, Toulouse University, Toulouse, Occitanie, France"},{"name":"INSERM CERPOP, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7282","authenticated-orcid":false,"given":"Isabelle","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Medical and Clinical Pharmacology Department, CHU Toulouse, Toulouse University, Toulouse, Occitanie, France"},{"name":"INSERM CERPOP, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2026010600251178000_11.1.e002049.1","doi-asserted-by":"publisher","DOI":"10.3109\/13816819209046487"},{"key":"2026010600251178000_11.1.e002049.2","doi-asserted-by":"publisher","DOI":"10.1080\/14766650252962649"},{"key":"2026010600251178000_11.1.e002049.3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/bdr2.1607","article-title":"Population-based birth defects data in the United States, 2012-2016: A focus on abdominal wall defects","volume":"111","author":"Stallings","year":"2019","journal-title":"Birth Defects Res"},{"key":"2026010600251178000_11.1.e002049.4","doi-asserted-by":"crossref","first-page":"103931","DOI":"10.1016\/j.jaapos.2024.103931","article-title":"The EFEMEREYE Study: prenatal medication exposure and ocular anomaly occurrence in EFEMERIS health database","volume":"28","author":"Dubucs","year":"2024","journal-title":"J AAPOS"},{"key":"2026010600251178000_11.1.e002049.5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(66)91142-1","article-title":"Minor ocular abnormalities associated with thalidomide","volume":"287","author":"Stanley Cant","year":"1966","journal-title":"The Lancet"},{"key":"2026010600251178000_11.1.e002049.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80142-5"},{"key":"2026010600251178000_11.1.e002049.7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: a systematic review","volume":"20","author":"Daw","year":"2011","journal-title":"Pharmacoepidemiology and Drug"},{"key":"2026010600251178000_11.1.e002049.8","doi-asserted-by":"publisher","DOI":"10.1177\/009286150804200501"},{"key":"2026010600251178000_11.1.e002049.9","unstructured":"ANSM . Dossier th\u00e9matique - anti\u00e9pileptique et grossesse. 2024. Available: https:\/\/ansm.sante.fr\/dossiers-thematiques\/medicaments-et- grossesse\/antiepileptique-et-grossesse"},{"key":"2026010600251178000_11.1.e002049.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb06226.x"},{"key":"2026010600251178000_11.1.e002049.11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/eye.2009.30","article-title":"Ocular teratogens: old acquaintances and new dangers","volume":"23","author":"Tandon","year":"2009","journal-title":"Eye (Lond)"},{"key":"2026010600251178000_11.1.e002049.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2009.02.007"},{"key":"2026010600251178000_11.1.e002049.13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome","volume":"60","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"key":"2026010600251178000_11.1.e002049.14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ajmg.a.34037","article-title":"Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations","volume":"155A","author":"Kozma","year":"2011","journal-title":"Am J Med Genet A"},{"key":"2026010600251178000_11.1.e002049.15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5935\/0004-2749.20140076","article-title":"Teratogen exposure and congenital ocular abnormalities in Brazilian patients with M\u00f6bius sequence","volume":"77","author":"Ventura","year":"2014","journal-title":"Arq Bras Oftalmol"},{"key":"2026010600251178000_11.1.e002049.16","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.48.3.151"},{"key":"2026010600251178000_11.1.e002049.17","first-page":"466","article-title":"Retinal degeneration in 2 children following preventive antimalarial treatment of the mother during pregnancy","volume":"69","author":"Paufique","year":"1969","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"2026010600251178000_11.1.e002049.18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcjo.2011.05.001","article-title":"The Peters anomaly following antenatal exposure to methotrexate and hydroxychloroquine","volume":"46","author":"Mulholland","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"2026010600251178000_11.1.e002049.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110686"},{"key":"2026010600251178000_11.1.e002049.20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2515\/therapie\/2013003","article-title":"Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns","volume":"68","author":"Tarfaoui","year":"2013","journal-title":"Therapie"},{"key":"2026010600251178000_11.1.e002049.21","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003"},{"key":"2026010600251178000_11.1.e002049.22","unstructured":"Centre UM . About vigibase. 2024. Available: https:\/\/who- umc.org\/vigibase\/"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-002049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:25:21Z","timestamp":1767687921000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-002049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjophth-2024-002049"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-002049","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}